has been cited by the following article(s):
|
[1]
|
The Characteristics of Dialysis Membranes: Benefits of the AN69 Membrane in Hemodialysis Patients
|
|
Journal of Clinical Medicine,
2023 |
|
|
|
|
[2]
|
Risk factors for heart, cerebrovascular, and kidney diseases: evaluation of potential side effects of medications to control hypertension, hyperglycemia, and …
|
|
Frontiers in Cardiovascular Medicine,
2023 |
|
|
|
|
[3]
|
Over-and under-provision of diabetes screening: making more efficient use of healthcare resources
|
|
Public Policy Review,
2023 |
|
|
|
|
[4]
|
A Generalized Heckman Model With Varying Sample Selection Bias and Dispersion Parameters
|
|
Souza, MG Genton - arXiv preprint arXiv …,
2020 |
|
|
|
|
[5]
|
Economic burden of ESRD to the Malaysian health care system
|
|
2019 |
|
|
|
|
[6]
|
International Comparisons of Economic Burden of EndStage Renal Disease to the National Healthcare Systems
|
|
2019 |
|
|
|
|
[7]
|
International Comparisons of Economic Burden of End-Stage Renal Disease to the National Healthcare Systems.
|
|
2019 |
|
|
|
|
[8]
|
Эпидемиология хронической болезни почек среди жителей города Москвы
|
|
2019 |
|
|
|
|
[9]
|
Epidemiology of chronic kidney disease among residents of Moscow
|
|
Clinical nephrology,
2019 |
|
|
|
|
[10]
|
Power transformation tobit model による健康診断・レセプトデータを使った医療費と生活習慣病の関連の分析
|
|
Power,
2019 |
|
|
|
|
[11]
|
Evaluation of Blood Pressure Control Medicines Using Health and Medical Checkup Data in Japan: Alternative Methods for Randomized Controlled Trials
|
|
2018 |
|
|
|
|
[12]
|
Does High Systolic Blood Pressure Truly Increase Medical Expenditure?—An Empirical Analysis of the New 2017 ACC/AHA Hypertension Guideline
|
|
2018 |
|
|
|
|
[13]
|
Empirical Studies of Effects of High Blood Pressure on Medical Costs and Heart Disease: Is the 2017 ACC/AHA Guideline Supported by Enough Evidence?
|
|
2018 |
|
|
|
|
[14]
|
БАБАЕВ ФАРИЗ ГАНИФА ОГЛЫ
|
|
|
|
|
|
|
[1]
|
The Characteristics of Dialysis Membranes: Benefits of the AN69 Membrane in Hemodialysis Patients
Journal of Clinical Medicine,
2023
DOI:10.3390/jcm12031123
|
|
|
|
|
[2]
|
Risk factors for heart, cerebrovascular, and kidney diseases: evaluation of potential side effects of medications to control hypertension, hyperglycemia, and hypercholesterolemia
Frontiers in Cardiovascular Medicine,
2023
DOI:10.3389/fcvm.2023.1103250
|
|
|
|
|
[3]
|
Economic Burden of End-Stage Renal Disease to the Malaysian Healthcare System
Kidney International Reports,
2019
DOI:10.1016/j.ekir.2019.05.016
|
|
|
|